Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1100212-67-6

Post Buying Request

1100212-67-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1100212-67-6 Usage

Indazole derivative

A heterocyclic compound with a five-membered ring and two nitrogen atoms

Trifluoromethyl group

Contributes to valuable properties for chemical and pharmaceutical applications

Building block

Used in the synthesis of biologically active compounds

Unique structure

Potential candidate for drug discovery and development

Applications in material science

Can be utilized in the development of new materials

Organometallic chemistry ligand

Can be used in the formation of organometallic compounds

Check Digit Verification of cas no

The CAS Registry Mumber 1100212-67-6 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,0,0,2,1 and 2 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1100212-67:
(9*1)+(8*1)+(7*0)+(6*0)+(5*2)+(4*1)+(3*2)+(2*6)+(1*7)=56
56 % 10 = 6
So 1100212-67-6 is a valid CAS Registry Number.

1100212-67-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 5-(trifluoromethyl)-1H-indazole-7-carbaldehyde

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1100212-67-6 SDS

1100212-67-6Downstream Products

1100212-67-6Relevant articles and documents

Substituted Heterocyclic Ethers and Their Use in CNS Disorders

-

Page/Page column 47, (2009/01/24)

The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating CNS disorders.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1100212-67-6